Investor Presentaiton
Financial Reconciliation Tables
Amkor
TechnologyⓇ
4Q12
2012
LTM 1Q13
Gross Margin
16%
15%
16%
Plus: Loss Contingency Charge Divided by Net Sales
2%
2%
1%
Adjusted Gross Margin
18%
17%
17%
Net Income ($ in millions)
Plus: Loss Contingency Charge, Net of Tax
Adjusted Net Income
$7
$42
$43
20
52
52
$27
$94
$95
Earnings per Diluted share
Plus: Loss Contingency Charge per Diluted Share
Adjusted Earnings per Diluted Share
$0.05
$0.24
$0.23
0.08
0.21
0.21
$0.13
$0.45
$0.44
EBITDA (1) ($ in millions)
$139
$527
$542
Plus: Cost of Goods Sold Portion of Loss Contingency Charge
Adjusted EBITDA (1)
20
50
50
$159
$577
$592
In this presentation we provide adjusted gross margin, adjusted net income, adjusted earnings per diluted share and adjusted EBITDA for the quarter and year ended December 31,
2012, and the twelve months ended March 31, 2013. We present these non-GAAP amounts to demonstrate the impact of the loss contingency we recognized for the quarter and year
ended December 31, 2012, and the twelve months ended March 31, 2013, related to our pending patent license arbitration with Tessera, Inc. However, these measures have limitations,
including that they exclude the charges for the Tessera arbitration award, which is an amount that the company may ultimately have to pay in cash. Furthermore, the factors affecting the
calculation of the arbitration award are complex and subject to determination by the arbitration panel. Therefore, the final amount of the loss may be more than the amount we have
recognized. Accordingly, these measures that exclude the loss contingency should be considered in addition to, and not as a substitute for, or superior to, gross margin, net income and
earnings per diluted share prepared in accordance with U.S. GAAP. Above is the reconciliation of adjusted gross margin, adjusted net income and adjusted earnings per diluted share to
U.S. GAAP gross margin, net income and earnings per diluted share.
(1)
See discussion of Non-GAAP measures on page 23
2013 Amkor Technology, Inc.
Amkor Confidential Information
224
24View entire presentation